EMA

  • Read more: Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    By Timo Minssen I am happy to announce the publication of our new working paper on  “Patenting Bioprinting Technologies in the US and Europe – The 5th element in the 3rd dimension.” The paper, which has  been co-authored by Marc Mimler, starts out by describing the state of the art and by examining what sorts of bioprinting inventions…

  • Read more: European Responses to the Ebola Crisis: Initiatives at the European Medicines Agency (EMA)

    European Responses to the Ebola Crisis: Initiatives at the European Medicines Agency (EMA)

    By Timo Minssen The current Ebola outbreak already attracted much attention on “Bill of Health” resulting in some excellent blogs on a horrible topic. While it is evident that the current health crisis requires both immediate responses and more sustainable changes in health care policy, research and regulation, medicines regulators are collaborating internationally to find innovative…